Approval · Notice of Compliance 35349 · 2025
TRODELVY: Notice of Compliance 35349
Issued May 14, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35349
- Date
- May 14, 2025
- Company
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph update.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRODELVY | Not yet assigned | — |
Medicinal ingredients
- SACITUZUMAB GOVITECAN 180 MG per VIAL